169 related articles for article (PubMed ID: 37222921)
1. Potential role of the P2X7 receptor in the proliferation of human diffused large B-cell lymphoma.
Yang X; Ji Y; Mei L; Jing W; Yang X; Liu Q
Purinergic Signal; 2024 Jun; 20(3):273-284. PubMed ID: 37222921
[TBL] [Abstract][Full Text] [Related]
2. Activating P2X7 Receptors Increases Proliferation of Human Pancreatic Cancer Cells via ERK1/2 and JNK.
Choi JH; Ji YG; Ko JJ; Cho HJ; Lee DH
Pancreas; 2018; 47(5):643-651. PubMed ID: 29683976
[TBL] [Abstract][Full Text] [Related]
3. P2X7 receptors at adult neural progenitor cells of the mouse subventricular zone.
Messemer N; Kunert C; Grohmann M; Sobottka H; Nieber K; Zimmermann H; Franke H; Nörenberg W; Straub I; Schaefer M; Riedel T; Illes P; Rubini P
Neuropharmacology; 2013 Oct; 73():122-37. PubMed ID: 23727220
[TBL] [Abstract][Full Text] [Related]
4. Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma.
Chen J; Xu-Monette ZY; Deng L; Shen Q; Manyam GC; Martinez-Lopez A; Zhang L; Montes-Moreno S; Visco C; Tzankov A; Yin L; Dybkaer K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Zhao X; Møller MB; Farnen JP; Winter JN; Piris MA; Pham L; Young KH
Oncotarget; 2015 Mar; 6(8):5597-614. PubMed ID: 25704881
[TBL] [Abstract][Full Text] [Related]
5. Feasibility study of B16 melanoma therapy using oxidized ATP to target purinergic receptor P2X7.
Hattori F; Ohshima Y; Seki S; Tsukimoto M; Sato M; Takenouchi T; Suzuki A; Takai E; Kitani H; Harada H; Kojima S
Eur J Pharmacol; 2012 Nov; 695(1-3):20-6. PubMed ID: 22981895
[TBL] [Abstract][Full Text] [Related]
6. Activation of P2X7 receptors decreases the proliferation of murine luteal cells.
Wang J; Liu S; Nie Y; Wu B; Wu Q; Song M; Tang M; Xiao L; Xu P; Tan X; Zhang L; Li G; Liang S; Zhang C
Reprod Fertil Dev; 2015 Nov; 27(8):1262-71. PubMed ID: 25782073
[TBL] [Abstract][Full Text] [Related]
7. Lenalidomide efficacy in activated B-cell-like subtype diffuse large B-cell lymphoma is dependent upon IRF4 and cereblon expression.
Zhang LH; Kosek J; Wang M; Heise C; Schafer PH; Chopra R
Br J Haematol; 2013 Feb; 160(4):487-502. PubMed ID: 23252516
[TBL] [Abstract][Full Text] [Related]
8. Human P2Y
Dreisig K; Sund L; Dommer MW; Kristensen NP; Boddum K; Viste R; Fredholm S; Odum N; Jäättelä M; Skov S; Kornum BR
Front Immunol; 2018; 9():1159. PubMed ID: 29937766
[TBL] [Abstract][Full Text] [Related]
9. Involvement of purinergic receptors and NOD-like receptor-family protein 3-inflammasome pathway in the adenosine triphosphate-induced cytokine release from macrophages.
Gicquel T; Victoni T; Fautrel A; Robert S; Gleonnec F; Guezingar M; Couillin I; Catros V; Boichot E; Lagente V
Clin Exp Pharmacol Physiol; 2014 Apr; 41(4):279-86. PubMed ID: 24472059
[TBL] [Abstract][Full Text] [Related]
10. Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma.
Zhang T; Guan XW; Gribben JG; Liu FT; Jia L
Cell Death Dis; 2019 Apr; 10(5):330. PubMed ID: 30988279
[TBL] [Abstract][Full Text] [Related]
11. P2X7 receptor promotes migration and invasion of non-small cell lung cancer A549 cells through the PI3K/Akt pathways.
Bai X; Li Q; Peng X; Li X; Qiao C; Tang Y; Zhao R
Purinergic Signal; 2023 Dec; 19(4):685-697. PubMed ID: 36854856
[TBL] [Abstract][Full Text] [Related]
12. Paracrine stimulation of P2X7 receptor by ATP activates a proliferative pathway in ovarian carcinoma cells.
Vázquez-Cuevas FG; Martínez-Ramírez AS; Robles-Martínez L; Garay E; García-Carrancá A; Pérez-Montiel D; Castañeda-García C; Arellano RO
J Cell Biochem; 2014 Nov; 115(11):1955-66. PubMed ID: 24913779
[TBL] [Abstract][Full Text] [Related]
13. Ionotropic purinergic receptor 7 (P2X7) channel structure and pharmacology provides insight regarding non-nucleotide agonism.
Al-Aqtash R; Collier DM
Channels (Austin); 2024 Dec; 18(1):2355150. PubMed ID: 38762911
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-26a/cyclin-dependent kinase 5 axis controls proliferation, apoptosis and in vivo tumor growth of diffuse large B-cell lymphoma cell lines.
Farina FM; Inguscio A; Kunderfranco P; Cortesi A; Elia L; Quintavalle M
Cell Death Dis; 2017 Jun; 8(6):e2890. PubMed ID: 28640256
[TBL] [Abstract][Full Text] [Related]
15. [Purinergic P2X family and specific features of the P2X7 subtype].
Jindrichová M; Zemková H
Cesk Fysiol; 2013; 62(2):40-6. PubMed ID: 24392594
[TBL] [Abstract][Full Text] [Related]
16. MiR-645 regulates the proliferation and apoptosis of diffuse large B-cell lymphoma by targeting DACH1.
Wang R; Shen J; Su N; Wang Q; Zhang M; Liu C
Hum Cell; 2020 Oct; 33(4):1091-1098. PubMed ID: 32529465
[TBL] [Abstract][Full Text] [Related]
17. Adenosine-5'-triphosphate suppresses proliferation and migration capacity of human endometrial stem cells.
Semenova S; Shatrova A; Vassilieva I; Shamatova M; Pugovkina N; Negulyaev Y
J Cell Mol Med; 2020 Apr; 24(8):4580-4588. PubMed ID: 32150662
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of proliferation and survival of diffuse large B-cell lymphoma cells by a small-molecule inhibitor of the ubiquitin-conjugating enzyme Ubc13-Uev1A.
Pulvino M; Liang Y; Oleksyn D; DeRan M; Van Pelt E; Shapiro J; Sanz I; Chen L; Zhao J
Blood; 2012 Aug; 120(8):1668-77. PubMed ID: 22791293
[TBL] [Abstract][Full Text] [Related]
19. C-MYC-activated lncRNA SNHG20 accelerates the proliferation of diffuse large B cell lymphoma via USP14-mediated deubiquitination of β-catenin.
Wang C; Fu W; Zhang Y; Hu X; Xu Q; Tong X
Biol Direct; 2024 Jun; 19(1):47. PubMed ID: 38886753
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the P2X7 receptor reduces cystogenesis in PKD.
Chang MY; Lu JK; Tian YC; Chen YC; Hung CC; Huang YH; Chen YH; Wu MS; Yang CW; Cheng YC
J Am Soc Nephrol; 2011 Sep; 22(9):1696-706. PubMed ID: 21636640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
